Erythroferrone, the new iron regulator: evaluation of its levels in Egyptian patients with beta thalassemia

Since iron overload is the commonest cause of morbidity and mortality in β thalassemia major (β-TM), it represents one major target in therapeutic management of the disease. The recently discovered erythroid regulator, erythroferrone ( ERFE ), governed by high levels of erythropoietin, was found to...

Ausführliche Beschreibung